✦ LIBER ✦

Management of Benign Prostatic Hyperplasia: Role of Phosphodiesterase-5 Inhibitors

✍ Scribed by Gacci, M.; Carini, M.; Salvi, M.; Sebastianelli, A.; Vignozzi, L.; Corona, G.; Maggi, M.; McVary, K. T.; Kaplan, S. A.; Oelke, M.; Serni, S.

Book ID: 125386884
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 370 KB
Volume: 31
Category: Article
ISSN: 1170-229X
DOI: 10.1007/s40266-014-0177-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tadalafil: A Phosphodiesterase-5 Inhibit

Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia

✍ Cantrell, Matthew A.; Baye, Jordan; Vouri, Scott Martin 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Management of Benign Prostatic Hyperplas

Management of Benign Prostatic Hyperplasia

✍ Katherine F. Croom, Antona J. Wagstaff 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 181 KB

Phosphodiesterase Type 5 Inhibitors for

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

✍ Huang, Shih-Tsung 📂 Article 📅 2010 🏛 Medknow Publications 🌐 English ⚖ 271 KB

Medical management of benign prostatic h

Medical management of benign prostatic hyperplasia

✍ Andrew Chacon; Manoj Monga 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 88 KB

Medical management of benign prostatic h

Medical management of benign prostatic hyperplasia

✍ Michael M. Kane; Douglas W. Fields; E. Darracott Vaughan Jr. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 903 KB

Phosphodiesterase 5 inhibitors for lower

Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review

✍ Humberto K. Laydner; Paulo Oliveira; Carlos Roberto A. Oliveira; Tafadzwa P. Mak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB